Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alembic Pharma to Form Joint Venture with Orbicular Pharma 11
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 12
Licensing Agreements 14
Novartis Enters into Licensing Agreement with Rhizen Pharma 14
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 15
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 16
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 17
Asset Transactions 18
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 18
Acquisition 19
Alembic Pharma Acquires Orit Labs 19
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 20
Alembic Pharmaceuticals Ltd – Key Competitors 21
Alembic Pharmaceuticals Ltd – Key Employees 22
Alembic Pharmaceuticals Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Jul 20, 2017: Alembic Pharmaceuticals: QI Net Revenue at Rs 648 Crores, Net Profit at Rs 65 Crores 25
May 03, 2017: Alembic Pharmaceuticals: Q4 Net Revenue grew 18% to Rs 740 Crores, Net Profit at Rs 94 cr 27
Jan 25, 2017: Alembic Pharmaceuticals: Q3 Net Profit at Rs 86 cr, Net Revenues at Rs 776 cr 28
Legal and Regulatory 29
Jun 15, 2018: Alembic Pharmaceuticals Receives Establishment Inspection Report For Its Formulation Facility At Panelav 29
May 18, 2018: Alembic Pharmaceuticals Provides Update on US FDA Inspection At its API Facility At Karkhadi 30
Apr 24, 2018: Alembic Pharmaceuticals: Update on Successful US FDA Inspection API Facility at Panelav 31
Mar 21, 2018: USFDA Inspection Formulation Facility at Panelav 32
Aug 31, 2017: Alembic Pharmaceuticals Receives EU GMP Certificate For Its Formulation Facility At Panelav 33
Mar 10, 2017: Alembic Pharmaceuticals Announces US FDA Inspection at Baroda Facility 34
Government and Public Interest 35
Apr 17, 2017: Successful US FDA Inspection at Alembic Pharmaceuticals Bioequivalence Facility at Baroda 35
Other Significant Developments 36
Aug 18, 2017: Alembic Pharmaceuticals: Disruption in plant operations at Algerian JV 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alembic Pharma to Form Joint Venture with Orbicular Pharma 11
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 12
Novartis Enters into Licensing Agreement with Rhizen Pharma 14
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 15
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 16
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 17
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 18
Alembic Pharma Acquires Orit Labs 19
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 20
Alembic Pharmaceuticals Ltd, Key Competitors 21
Alembic Pharmaceuticals Ltd, Key Employees 22
Alembic Pharmaceuticals Ltd, Other Locations 23
Alembic Pharmaceuticals Ltd, Subsidiaries 23
List of Figures
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9